Page 1929 - Williams Hematology ( PDFDrive )

1904 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1905

1196. Tilley DO, et al: Glycoprotein Ibalpha and FcgammaRIIa play key roles in platelet 1227. Hartwell DW, et al: Role of P-selectin cytoplasmic domain in granular targeting in
activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost 11(5): vivo and in early inflammatory responses. J Cell Biol 143(4):1129–1141, 1998.
941–950, 2013. 1228. Geng JG, et al: Rapid neutrophil adhesion to activated endothelium mediated by
1197. Mitrugno A, et al: A novel and essential role for FcgammaRIIa in cancer cell-induced GMP-140. Nature 343:757–760, 1990.
platelet activation. Blood 123(2):249–260, 2014. 1229. Handa K, et al: Selectin GMP-140 (CD62;PADGEM) binds to sialosyl-Le(a) and
1198. Chong BH, et al: Increased expression of platelet IgG Fc receptors in immune heparin- sialosyl-Le(x), and sulfated glycans modulate this binding. Biochem Biophys Res
induced thrombocytopenia. Blood 81(4):988–993, 1993. Commun 181:1223–1230, 1991.
1199. Parren PW, et al: On the interaction of IgG subclasses with the low affinity Fc gamma 1230. Polley MJ, et al: CD62 and endothelial cell-leukocyte adhesion molecule I (ELAM-
RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional 1) recognize the same carbohydrate ligand, sialyl-Lewisx. Proc Natl Acad Sci U S A
polymorphism to human IgG2. J Clin Invest 90(4):1537–1546, 1992. 88:6224–6228, 1991.
1200. Warmerdam PA, et al: Polymorphism of the human Fc gamma receptor II (CD32): 1231. Aruffo A, et al: CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell
Molecular basis and functional aspects. Immunobiology 185(2–4):175–182, 1992. 67:35–44, 1991.
1201. Chen J, et al: Platelet FcgammaRIIA His131Arg polymorphism and platelet function: 1232. Stone JP, Wagner DD: P-selectin mediates adhesion of platelets to neuroblastoma and
Antibodies to platelet-bound fibrinogen induce platelet activation. J Thromb Haemost small cell lung cancer. J Clin Invest 92:804–813, 1993.
1(2):355–362, 2003. 1233. McEver RP, Cummings RD: Perspectives series: Cell adhesion in vascular biology. Role
1202. Carlsson LE, et al: Heparin-induced thrombocytopenia: New insights into the impact of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100(3):485–491,
of the FcgammaRIIa-R-H131 polymorphism. Blood 92(5):1526–1531, 1998. 1997.
1203. Denomme GA, et al: Activation of platelets by sera containing IgG1 heparin-depen- 1234. Sako D, et al: Expression cloning of a functional glycoprotein ligand for P-selectin.
dent antibodies: An explanation for the predominance of the Fc gammaRIIa “low Cell 75(6):1179–1186, 1993.
responder” (his131) gene in patients with heparin-induced thrombocytopenia. J Lab 1235. Yang J, Furie BC, Furie B: The biology of P-selectin glycoprotein ligand-1: Its role as a
Clin Med 130(3):278–284, 1997. selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction.
1204. Gruel Y, et al: The homozygous FcgammaRIIIa-158V genotype is a risk factor for Thromb Haemost 81(1):1–7, 1999.
heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet 1236. Falati S, et al: Accumulation of tissue factor into developing thrombi in vivo is depen-
factor 4 complexes. Blood 104(9):2791–2793, 2004. dent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp
1205. Kannan M, et al: An update on the prevalence and characterization of H-PF4 antibod- Med 197(11):1585–1598, 2003.
ies in Asian-Indian patients. Semin Thromb Hemost 35(3):337–343, 2009. 1237. Celi A, et al: P-selectin induces the expression of tissue factor on monocytes. Proc Natl
1206. Trikalinos TA, Karassa FB, Ioannidis JP: Meta-analysis of the association between Acad Sci U S A 91(19):8767–8771, 1994.
low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoim- 1238. Theoret JF, et al: P-selectin ligation induces platelet activation and enhances microag-
mune disease. Blood 98(5):1634–1635, 2001. gregate and thrombus formation. Thromb Res 128(3):243–250, 2011.
1207. Williams Y, et al: Correlation of platelet Fc gammaRIIA polymorphism in refractory 1239. Ridker PM, Buring JE, Rifai N, Soluble P-selectin and the risk of future cardiovascular
idiopathic (immune) thrombocytopenic purpura. Br J Haematol 101(4):779–782, 1998. events. Circulation 103(4):491–495, 2001.
1208. Diacovo TG, et al: A functional integrin ligand on the surface of platelets: Intercellular 1240. Mayadas TN, et al: Leukocyte rolling and extravasation are severely compromised in
adhesion molecule-2. J Clin Invest 94(3):1243–1251, 1994. P selectin-deficient mice. Cell 74(3):541–554, 1993.
1209. Hasegawa S, et al: Functional expression of the high affinity receptor for IgE 1241. Frenette PS, et al: Platelets roll on stimulated endothelium in vivo: An interaction
(FcepsilonRI) in human platelets and its’ intracellular expression in human megakary- mediated by endothelial P-selectin. Proc Natl Acad Sci U S A 92(16):7450–7454,
ocytes. Blood 93(8):2543–2551, 1999. 1995.
1210. Joseph M, et al: Expression and functions of the high-affinity IgE receptor on human 1242. Padilla A, et al: P-selectin anchors newly released ultralarge von Willebrand factor
platelets and megakaryocyte precursors. Eur J Immunol 27(9):2212–2218, 1997. multimers to the endothelial cell surface. Blood 103(6):2150–2156, 2004.
1211. Kasperska-Zajac A, Rogala B: Platelet function in anaphylaxis. J Investig Allergol Clin 1243. Cambien B, Wagner DD: A new role in hemostasis for the adhesion receptor
Immunol 16(1):1–4, 2006. P-selectin. Trends Mol Med 10(4):179–186, 2004.
1212. Gupta SK, Pillarisetti K, Ohlstein EH: Platelet agonist F11 receptor is a member of 1244. Ludwig RJ, Schon MP, Boehncke WH: P-selectin: A common therapeutic target for
the immunoglobulin superfamily and identical with junctional adhesion mole- cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther
cule (JAM): Regulation of expression in human endothelial cells and macrophages. Targets 11(8):1103–1117, 2007.
IUBMB Life 50(1):51–56, 2000. 1245. Polanowska-Grabowska R, et al: P-selectin-mediated platelet-neutrophil aggregate
1213. Kornecki E, et al: Activation of human platelets by a stimulatory monoclonal anti- formation activates neutrophils in mouse and human sickle cell disease. Arterioscler
body. J Biol Chem 265(17):10042–10048, 1990. Thromb Vasc Biol 30(12):2392–2399, 2010.
1214. Naik UP, et al: Characterization and chromosomal localization of JAM-1, a platelet 1246. Polgar J, Matuskova J, Wagner DD: The P-selectin, tissue factor, coagulation triad. J
receptor for a stimulatory monoclonal antibody. J Cell Sci 114(Pt 3):539–547, 2001. Thromb Haemost 3(8):1590–1596, 2005.
1215. Sobocka MB, et al: Cloning of the human platelet F11 receptor: A cell adhesion mol- 1247. Navarro-Nunez L, et al: The physiological and pathophysiological roles of platelet
ecule member of the immunoglobulin superfamily involved in platelet aggregation. CLEC-2. Thromb Haemost 109(6):991–998, 2013.
Blood 95(8):2600–2609, 2000. 1248. Ozaki Y, Suzuki-Inoue K, Inoue O: Novel interactions in platelet biology: CLEC-2/
1216. Sobocki T, et al: Genomic structure, organization and promoter analysis of the human podoplanin and laminin/GPVI. J Thromb Haemost 7(Suppl 1):191–194, 2009.
F11R/F11 receptor/junctional adhesion molecule-1/JAM-A. Gene 366(1):128–144, 2006. 1249. Schacht V, et al: T1alpha/podoplanin deficiency disrupts normal lymphatic vascula-
1217. Naik MU, et al: JAM-A protects from thrombosis by suppressing integrin ture formation and causes lymphedema. EMBO J 22(14):3546–3556, 2003.
alphaIIbbeta3-dependent outside-in signaling in platelets. Blood 119(14):3352–3360, 1250. Tsuruo T, Fujita N: Platelet aggregation in the formation of tumor metastasis. Proc Jpn
2012. Acad Ser B Phys Biol Sci 84(6):189–198, 2008.
1218. Naik MU, Caplan JL, Naik UP: Junctional adhesion molecule-A suppresses platelet 1251. Christou CM, et al: Renal cells activate the platelet receptor CLEC-2 through podopla-
integrin alphaIIbbeta3 signaling by recruiting Csk to the integrin-c-Src complex. nin. Biochem J 411(1):133–140, 2008.
Blood 123(9):1393–1402, 2014. 1252. Gitz E, et al: CLEC-2 expression is maintained on activated platelets and on platelet
1219. Stellos K, et al: Expression of junctional adhesion molecule-C on the surface of plate- microparticles. Blood 124(14):2262–2270, 2014.
lets supports adhesion, but not differentiation, of human CD34 cells in vitro. Cell Phys- 1253. Suzuki-Inoue K, et al: Involvement of the snake toxin receptor CLEC-2, in
iol Biochem 29(1–2):153–162, 2012. podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 282(36):
1220. McEver RP: Properties of GMP-140, an inducible granule membrane protein of plate- 25993–26001, 2007.
lets and endothelium. Blood Cells 16:73–83, 1990. 1254. Watson AA, et al: The platelet receptor CLEC-2 is active as a dimer. Biochemistry
1221. McEver RP, P-selectin/PSGL-1 and other interactions between platelets, leukocytes, 48(46):10988–10996, 2009.
and endothelium, in Platelets, edited by AD Michelson, p 231. Academic Press, San 1255. Gitz E, et al: CLEC-2 expression is maintained on activated platelets and on platelet
Diego, 2007. microparticles. Blood 124(14):2262–2270, 2014.
1222. McEver RP, Beckstead JH, Moore KL, et al: GMP-140, a platelet -granule mem- 1256. Lowe KL, Navarro-Nunez L, Watson SP: Platelet CLEC-2 and podoplanin in cancer
brane protein, is also synthesized by vascular endothelial cells and is localized in metastasis. Thromb Res 129 Suppl 1:S30–S37, 2012.
Weibel-Palade bodies. J Clin Invest 84(1):92–99, 1989. 1257. Bertozzi CC, et al: Platelets regulate lymphatic vascular development through CLEC-
1223. Yong AS, et al: Intracoronary shear-related up-regulation of platelet P-selectin and 2-SLP-76 signaling. Blood 116(4):661–670, 2010.
platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood 1258. Pollitt AY, et al: Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-
2011;117(1):11–20, 1989. mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial
1224. Abrams C, Shattil SJ: Immunological detection of activated platelets in clinical disor- cells. J Biol Chem 289(52):35695–35710, 2014.
ders. J Thromb Haemost 65(5):467–473, 1991. 1259. Suzuki-Inoue K, et al: Essential in vivo roles of the C-type lectin receptor CLEC-2:
1225. Haskard DO: Adhesive proteins, in Haemostasis and Thrombosis, edited by AL Bloom, Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic miscon-
CD Forbes, DP Thomas, EGD Tuddenham, pp 233–257. Churchill Livingstone, nections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem
England, 1994. 285(32):24494–24507, 2010.
1226. Ishiwata N, et al: Alternatively spliced isoform of P-selectin is present in vivo as a 1260. Benezech C, et al: CLEC-2 is required for development and maintenance of lymph
soluble molecule. J Biol Chem 269(38):23708–23715, 1994. nodes. Blood 123(20):3200–3207, 2014.

Kaushansky_chapter 112_p1829-1914.indd 1904 17/09/15 3:30 pm